VA North Texas Health Care System
Dallas, Texas 75216
We've found
9 trials
at this facility
Peripheral Arterial Disease Antiplatelet Therapy Clinical Trial
Updated: 12/11/2014
Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities (ASPIRE PAD)
Status: Enrolling,
Phase
III
Updated: 12/11/2014
Click here to add this to my saved trials
Smoldering Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Coronary Heart Disease Clinical Trial
Updated: 12/31/1969
Mobile Health Strategies for Veterans
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial
Updated: 10/10/2013
Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT)
Status: Enrolling
Updated: 10/10/2013
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Updated: 12/31/1969
Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Updated: 12/31/1969
Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis (MS) Clinical Trial
Updated: 12/31/1969
Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials